Literature DB >> 6790292

Genetic control of the immune response to staphylococcal nuclease. XI. Effects of in vivo administration of anti-idiotypic antibodies.

D H Sachs, M El-Gamil, G Miller.   

Abstract

The effects of prior treatment with heterologous anti-idiotypic antibodies on the response to staphylococcal nuclease (Nase) have been examined. Previous studies have shown that 100% of A/J mice treated with Nase in completes Freund's adjuvant produce anti-Nase antibodies possessing a characteristic idiotype (Id). Mice treated with anti-Id antibodies followed by Nase produced levels of Id equal to or greater than those of control animals treated with Nase alone. The appearance of Id in treated mice preceded the appearance of anti-Nase activity, and animals treated with anti-Id alone produced high levels of Id without detectable anti-Nase activity. Id expression in such animals could be detected using anti-Id reagents produced in several different species suggesting that it represented true idiotope expression rather than unrelated molecules reactive only with the anti-Id reagent used for initial treatment. Isolation of the nonantigen-binding Id-bearing molecules (Id') showed them to be immunoglobulins bearing the same idiotopes as do anti-Nase antibodies. However, quantitative comparisons of Id levels vs. amount of Id or Id'-bearing immunoglobulin suggested that the nonantigen-binding immunoglobulins bore fewer idiotopes per molecule than did anti-Nase antibodies. Evidence was also obtained for the production of some nonantigen-binding Id-bearing molecules during the normal immune response Nase. These findings are therefore consistent with the existence of a network of Id-anti-Id interactions in the immune response to Nase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790292     DOI: 10.1002/eji.1830110613

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Anti-idiotype to monoclonal anti-swine SLA antibody detects a common idiotype shared by mouse anti-SLA sera and elicits an anti-SLA activity.

Authors:  R Rabinowitz; M D Pescovitz; D H Sachs
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

Review 2.  Induction of immune responses with anti-idiotypic antibodies: implications for the induction of protective immunity.

Authors:  D L Sacks; G H Kelsoe; D H Sachs
Journal:  Springer Semin Immunopathol       Date:  1983

3.  Anti-idiotypes against anti-H-2 monoclonal antibodies: structural analysis of the molecules induced by in vivo anti-idiotype treatment.

Authors:  J A Bluestone; H C Krutzsch; H Auchincloss; P A Cazenave; T J Kindt; D H Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

4.  Genetic control of the immune response to staphylococcal nuclease. X. Isoelectric focusing spectrotypes of antinuclease antibodies detected by labeling with antigen and with anti-idiotype.

Authors:  G P Miller; D H Sachs
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

5.  Idiotypic manipulation in mice: BALB/c mice can express the crossreactive idiotype of A/J mice.

Authors:  M Moser; O Leo; J Hiernaux; J Urbain
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

6.  Idiotypic analysis of potential and available repertoires in the arsonate system.

Authors:  M Slaoui; O Leo; J Marvel; M Moser; J Hiernaux; J Urbain
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

7.  Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice.

Authors:  G T Nepom; K A Nelson; S L Holbeck; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Modulation of immune response to Lol p I by pretreatment with anti-idiotypic antibody is not restricted to the idiotypic expression.

Authors:  Y Boutin; J Hébert
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Antiidiotype modulation of herpes simplex virus infection leading to increased pathogenicity.

Authors:  R C Kennedy; K Adler-Storthz; J W Burns; R D Henkel; G R Dreesman
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

10.  Anti-ids in allergy: timeliness of a classic concept.

Authors:  Julia Wallmann; Isabella Pali-Schöll; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2010-06       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.